XML 105 R89.htm IDEA: XBRL DOCUMENT v3.10.0.1
Out-License of MARQIBO, ZEVALIN, & EVOMELA in China Territory - Schedule of Proceeds Received and Fair Value on CASI Out-License Execution Date (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
12 Months Ended
Sep. 17, 2014
Dec. 31, 2017
Dec. 31, 2016
Secured Promissory Note [Member]      
Other Commitments [Line Items]      
Debt instrument face value $ 1,500    
CASI Out License [Member]      
Other Commitments [Line Items]      
Total consideration received $ 9,959    
Shares received (shares) 5.4 1.5 4.6
Stock price on the NASDAQ Capital Market ($ per share) $ 1.6    
CASI Out License [Member] | Secured Promissory Note [Member]      
Other Commitments [Line Items]      
Total consideration received $ 1,310    
Debt instrument coupon rate 0.50%    
CASI Out License [Member] | Common Stock [Member]      
Other Commitments [Line Items]      
Total consideration received $ 8,649